Menu Search
Equities

Resmed Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
RMD:ASX

Resmed Inc

Actions
  • Price (AUD)36.79
  • Today's Change-1.82 / -4.71%
  • Shares traded1.03m
  • 1 Year change-2.72%
  • Beta--
Data delayed at least 20 minutes, as of Feb 11 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		RMD:NYQ since
announced		Transaction
value
VirtuOx IncDeal completed01 May 202501 May 2025Deal completed16.64%--
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.

Institutional shareholders

3.09%Per cent of shares held by top holders
HolderShares% Held
Vanguard Investments Australia Ltd.as of 31 Dec 20259.81m0.67%
Australian Foundation Investment Co. Ltd. (Invt Mgmt)as of 30 Jun 20256.43m0.44%
Schroder Investment Management (Singapore) Ltd.as of 31 Dec 20256.10m0.42%
BetaShares Capital Ltd.as of 30 Jan 20264.60m0.32%
AllianceBernstein Investments Taiwan Ltd.as of 30 Sep 20254.32m0.30%
First Sentier Investors (Hong Kong) Ltd.as of 30 Sep 20253.93m0.27%
The Caisse de d�p�t et placement du Qu�becas of 31 Dec 20243.79m0.26%
FIL Investment Management (Australia) Ltd.as of 31 Dec 20252.42m0.17%
BlackRock Investment Management (Australia) Ltd.as of 05 Jan 20261.98m0.14%
BlackRock Asset Management North Asia Ltd.as of 31 Oct 20251.81m0.12%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.